Pregabalin versus placebo in targeting pro-nociceptive mechanisms to prevent chronic pain after whiplash injury in at-risk individuals – a feasibility study for a randomised controlled trial

BACKGROUND: Whiplash-associated disorders (WAD) are an enormous and costly burden to Australian society. Up to 50% of people who experience a whiplash injury will never fully recover. Whiplash is resistant to treatment and no early management approach has yet been shown to prevent chronic pain. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikles, J., Keijzers, G., Mitchell, G., Schug, S., Ware, R., McLean, S. A., Connelly, L., Gibson, S., Farrell, S. F., Sterling, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773126/
https://www.ncbi.nlm.nih.gov/pubmed/29343280
http://dx.doi.org/10.1186/s13063-018-2450-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773126/
https://www.ncbi.nlm.nih.gov/pubmed/29343280
http://dx.doi.org/10.1186/s13063-018-2450-9

Ejemplares similares